Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Pharmacol Physiol ; 44(3): 371-377, 2017 03.
Article in English | MEDLINE | ID: mdl-27998005

ABSTRACT

Ischaemic acute kidney injury (AKI) is a leading killer of both sexes; however, resistance to this injury is higher among women than men. We found that renal venous noradrenaline (NAd) overflow after reperfusion played important roles in the development of ischaemic AKI, and that the attenuation of AKI observed in female rats may be dependent on depressing the renal sympathetic nervous system with endogenous oestrogen. In the present study, we used male and female Sprague-Dawley rats to investigate whether sex differences in the pathogenesis of ischaemic AKI are related to the degradation of NAd by monoamine oxidase (MAO) in the kidney. Ischaemic AKI was achieved by clamping the left renal artery and vein for 45 minutes followed by reperfusion 2 weeks after contralateral nephrectomy. Renal injury was more severe in male rats than in female rats and renal venous plasma NAd levels after reperfusion were markedly elevated in males, but not in females. These sex differences were eliminated by a treatment with isatin, a non-selective MAO inhibitor, and moclobemide, a selective MAOA inhibitor, but not by selegiline, a selective MAOB inhibitor. Ischaemia decreased the mRNA expression levels of both MAOs in the kidney 1 day after reperfusion; however, MAOA mRNA expression levels were higher in female rats than in male rats. These results suggest that the degradation of NAd by MAOA in the kidney contributes to sex differences in the pathogenesis of ischaemia/reperfusion-induced AKI.


Subject(s)
Kidney/blood supply , Monoamine Oxidase/metabolism , Norepinephrine/blood , Reperfusion Injury/etiology , Sex Characteristics , Animals , Female , Kidney/metabolism , Kidney/pathology , Kidney Function Tests , Male , Monoamine Oxidase/genetics , Monoamine Oxidase Inhibitors/pharmacology , Nephrectomy , RNA, Messenger/genetics , Rats, Sprague-Dawley , Reperfusion Injury/blood , Reperfusion Injury/enzymology , Reperfusion Injury/pathology
2.
J Cardiovasc Pharmacol ; 63(1): 9-15, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24084211

ABSTRACT

Time-dependent changes in the renal sympathetic nerve activity (RSNA) in the progression of chronic kidney disease (CKD) have not been investigated, despite the fact that renal sympathetic nervous system is augmented in the condition of CKD. In the present study, we examined time-dependent changes in RSNA and renal venous norepinephrine concentrations for 12 weeks using 5 of 6 nephrectomized CKD rats. Both RSNA and norepinephrine concentrations were increased during the early phase in the progression of CKD. Urinary protein excretion and systolic blood pressure (SBP) were gradually increased during 12 weeks after 5 of 6 nephrectomy. Treatment with γ-aminobutyric acid or the combination of prazosin and propranolol in the early phase (0-4 weeks) after 5 of 6 nephrectomy significantly attenuated the increases in urinary protein excretion and SBP in 5 of 6 nephrectomized rats. On the other hand, the same treatment in the late phase (8-12 weeks) after 5 of 6 nephrectomy failed to suppress the proteinuria and increase in SBP. Treatment with hydralazine at hypotensive dose for 12 weeks also failed to affect the proteinuria in 5 of 6 nephrectomized CKD rats. In conclusion, the augmentation of renal sympathetic nervous system in early phase after 5 of 6 nephrectomy is closely related to the development of partial ablation-induced CKD in rats.


Subject(s)
Autonomic Nervous System Diseases/physiopathology , Renal Insufficiency, Chronic/physiopathology , Adrenergic alpha-Antagonists/pharmacology , Adrenergic beta-Antagonists/pharmacology , Animals , Antihypertensive Agents/pharmacology , Blood Pressure/physiology , Disease Progression , GABA Agents/pharmacology , Hydralazine/pharmacology , Kidney/innervation , Kidney Function Tests , Male , Nephrectomy , Norepinephrine/metabolism , Peripheral Nerves/physiology , Prazosin/pharmacology , Propranolol/pharmacology , Rats , Rats, Sprague-Dawley , Sympathetic Nervous System/physiopathology , gamma-Aminobutyric Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL